Senior Medical Director, Pulmonary Hypertension, Global Medical Affairs

MSD•North Wales, PA

2d•$282,200 - $444,200•Remote

About The Position

The Global Senior Director Medical Affairs (GDMA) position is part of the Value & Implementation (V&I) organization, which includes Global Medical and Scientific Affairs (GMSA) and Outcomes Research. The GDMA is a subject-matter expert in Pulmonary Hypertension and drives execution of the GMSA portion of Global V&I Plans for assigned therapeutic areas. The role focuses on the United States while also supporting the rest of the world, and contributes specialized medical expertise, business judgment, and decision-making as part of a high-performing, results-driven team. The GDMA works with country and regional medical affairs colleagues and partners across clinical development, outcomes research, policy, commercial, market access, and other functions. The role translates global scientific platforms into actionable medical value narratives, incorporates country-specific insights into global plans, engages scientific and other external stakeholders, and leads activities such as expert-input events, symposia, educational meetings, and support for local data generation. The position also manages assigned programs and budgets, championing innovation, medical modernization, and patient impact. The role is based remotely, with the primary posting location in Rahway, New Jersey. Travel requirements are 50%. The listed base salary range for the primary location is $282,200 to $444,200, and the successful candidate may be eligible for an annual bonus and long-term incentive, if applicable. Domestic relocation is indicated; visa sponsorship is not available.

Requirements

M.D., Ph.D., or Pharm.D.; M.D. preferred.
Recognized medical expertise.
Experience in country- or region-level Medical Affairs or clinical development.
Strong prioritization and decision-making skills.
Ability to collaborate effectively across divisions in a matrix environment.
Excellent interpersonal, analytical, written, and oral communication skills.
Results-oriented project-management skills.
Required skills listed: Cardiology, Communication, Medical Affairs, Pharmaceutical Industry, Pulmonary Arterial Hypertension, and Strategic Planning.

Nice To Haves

Pulmonary Hypertension therapeutic-area experience is preferred.
At least three years of regional medical affairs experience, such as Regional Director Medical Affairs, with a proven track record of contributing to medical-affairs strategies.
Customer expertise in the assigned therapeutic area, especially with scientific leaders and other key stakeholders such as payers, public groups, government officials, and medical professional organizations.

Responsibilities

Drive execution of the annual V&I plan with medical affairs colleagues in key countries and regions, with a focus on the United States, making informed decisions with a strategic and agile mindset.
Serve as the subject-matter expert and connector across assigned therapeutic areas, translating global scientific platforms into actionable Medical Value Narratives.
Engage country-level stakeholders, including medical advisors, payers, and scientific leaders, to ensure strategic alignment and support local data generation, congress planning, and advisory boards.
Represent Medical Affairs on Product Development sub-teams, including Clinical, V&I, Commercial, Publications, and Label, and use the V&I GMSA vision to guide strategic planning, outcome delivery, and tactical execution.
Communicate pertinent information to stakeholders, including EDMA, RSL, RDMA, US DMA, and PASLs, to inform and influence country and regional planning.
Collaborate with V&I Outcomes Research, Policy, Commercial, and Market Access teams to identify and address opportunities and barriers in key countries.
Partner strategically with the United States, China, and Japan where there is no RDMA role, bridging global strategy with local execution and integrating country-specific insights into global V&I plans.
Consolidate actionable medical insights from countries and regions.
Engage international scientific leaders and other stakeholders—including guideline committees, payers, public groups, government officials, and medical societies—on emerging science, building internal and external networks and partnerships.
Monitor changes in the external environment in partnership with the competitive intelligence team.
Organize global advisory boards and expert-input forums to address questions about developing and implementing new medicines or vaccines.
Collaborate with Global Human Health executive directors to inform them about the GMSA portion of V&I plans, ensure alignment, and independently lead execution of those plans.
Organize global symposia and educational meetings.
Support key countries, when requested, with development of local data-generation study concepts and protocols.
Review Investigator-Initiated Study proposals from key countries outside the U.S. before headquarters submission, in collaboration with RDMAs; serve on review panels for therapeutic-area-specific out-company Investigator Studies Programs (MISPs) to support the EDSA review process.
Manage patient-support, educational, or risk-management programs that support appropriate and safe use of company medicines or vaccines.
Champion the company's Ways of Working, emphasizing innovation, medical modernization, team priorities, and patient impact.
Manage the assigned budget with strong financial stewardship, deliver within a 3% variance, and make informed decisions when budgets change during the year.